Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

Similar articles for PubMed (Select 20370845)

1.

Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.

Sandner-Kiesling A, Leyendecker P, Hopp M, Tarau L, Lejcko J, Meissner W, Sevcik P, Hakl M, Hrib R, Uhl R, Dürr H, Reimer K.

Int J Clin Pract. 2010 May;64(6):763-74. doi: 10.1111/j.1742-1241.2010.02360.x. Epub 2010 Mar 29.

2.

Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K.

J Pain. 2008 Dec;9(12):1144-54. doi: 10.1016/j.jpain.2008.06.014. Epub 2008 Aug 16.

PMID:
18708300
3.

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K.

Curr Med Res Opin. 2008 Dec;24(12):3503-12. doi: 10.1185/03007990802584454 .

PMID:
19032132
4.

Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.

Löwenstein O, Leyendecker P, Hopp M, Schutter U, Rogers PD, Uhl R, Bond S, Kremers W, Nichols T, Krain B, Reimer K.

Expert Opin Pharmacother. 2009 Mar;10(4):531-43. doi: 10.1517/14656560902796798 .

PMID:
19243306
5.
6.
7.

Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.

Hermanns K, Junker U, Nolte T.

Expert Opin Pharmacother. 2012 Feb;13(3):299-311. doi: 10.1517/14656566.2012.648615. Epub 2012 Jan 6.

PMID:
22224497
8.

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.

Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.

Eur J Pain. 2009 Jan;13(1):56-64. doi: 10.1016/j.ejpain.2008.06.012. Epub 2008 Aug 31.

PMID:
18762438
9.

A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy.

Comelon M, Wisloeff-Aase K, Raeder J, Draegni T, Undersrud H, Qvigstad E, Bjerkelund CE, Lenz H.

Acta Anaesthesiol Scand. 2013 Apr;57(4):509-17. doi: 10.1111/aas.12051. Epub 2013 Jan 10.

PMID:
23301686
10.

Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice.

Schutter U, Grunert S, Meyer C, Schmidt T, Nolte T.

Curr Med Res Opin. 2010 Jun;26(6):1377-87. doi: 10.1185/03007991003787318.

PMID:
20380506
11.

A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.

Arora S, Setnik B, Michael D, Hudson JD, Clemmer R, Meisner P, Pixton GC, Goli V, Sommerville KW.

J Opioid Manag. 2014 Nov-Dec;10(6):423-36. doi: 10.5055/jom.2014.0239.

PMID:
25531960
12.

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.

Rentz AM, Yu R, Müller-Lissner S, Leyendecker P.

J Med Econ. 2009;12(4):371-83. doi: 10.3111/13696990903430481.

PMID:
19912069
13.

Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.

Gatti A, Casali M, Lazzari M, Tufaro G, Gafforio P, Silvestri C, Marcassa C, Sabato AF.

Adv Ther. 2013 Jan;30(1):41-59. doi: 10.1007/s12325-012-0074-0. Epub 2012 Dec 21.

PMID:
23269562
14.

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.

Smith K, Hopp M, Mundin G, Leyendecker P, Bailey P, Grothe B, Uhl R, Reimer K.

Clin Ther. 2008 Nov;30(11):2051-68. doi: 10.1016/j.clinthera.2008.11.008.

PMID:
19108793
15.
16.

Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain.

Nadstawek J, Leyendecker P, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.

Int J Clin Pract. 2008 Aug;62(8):1159-67. doi: 10.1111/j.1742-1241.2008.01820.x.

17.

Prolonged-release oxycodone/naloxone in postoperative pain management: from a randomized clinical trial to usual clinical practice.

Kuusniemi K, Zöllner J, Sjövall S, Huhtala J, Karjalainen P, Kokki M, Lemken J, Oppermann J, Kokki H.

J Int Med Res. 2012;40(5):1775-93.

PMID:
23206459
18.

Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials.

Blagden M, Hafer J, Duerr H, Hopp M, Bosse B.

Neurogastroenterol Motil. 2014 Dec;26(12):1792-801. doi: 10.1111/nmo.12463. Epub 2014 Oct 23.

19.

Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.

Clemens KE, Quednau I, Klaschik E.

Int J Clin Pract. 2011 Apr;65(4):472-8. doi: 10.1111/j.1742-1241.2011.02634.x.

PMID:
21401835
20.

High doses of oxycodone-naloxone combination may provide poor analgesia.

Mercadante S, Ferrera P, Adile C.

Support Care Cancer. 2011 Sep;19(9):1471-2. doi: 10.1007/s00520-011-1205-x. Epub 2011 Jun 9.

PMID:
21656338
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk